Infect Chemother.  2025 Mar;57(1):172-178. 10.3947/ic.2024.0130.

Poor Prognosis of Pneumococcal Co-Infection in Hospitalized Patients with COVID-19: A Propensity Score-Matched Analysis

Affiliations
  • 1Department of Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
  • 2Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, Daegu, Korea
  • 3Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea
  • 4Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Korea
  • 5Department of Medical Information, Kyungpook National University Hospital, Daegu, Korea

Abstract

The impact of Streptococcus pneumoniae coinfection on coronavirus disease 2019 (COVID-19) prognosis remains uncertain. We conducted a retrospective analysis of patients hospitalized with COVID-19 who underwent a pneumococcal urinary antigen (PUA) test to assess its clinical utility. Results showed that PUA-positive patients required more oxygen support, high-flow nasal cannula, and dexamethasone compared to PUA-negative patients. Furthermore, the significantly higher incidence of a National Early Warning Score ≥5 in the PUA-positive group (P<0.001) suggests that a positive PUA test is associated with a severe disease course. However, no significant difference in mortality was observed between the two groups, and antibiotics were used in almost all patients (96.2%). While the PUA test may help guide antibiotic use in COVID-19 patients, its interpretation should be approached with caution.

Keyword

Coronavirus Disease 2019; Streptococcus pneumoniae; Co-infection; Antibiotics
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr